This is a phase I study to evaluate the safety of ALLO-ASC-DFU for the treatment of deep second-degree burn wound patients. ALLO-ASC-DFU is a hydrogel sheet containing allogenic adipose-derived mesenchymal stem cells. Adipose-derived stem cells release growth factors such as vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), which can enhance wound healing and regeneration of new tissue, finally may provide a new option in treating a burn.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
5
Dressing for second-degree burn wound.
Hallym university Medical Center
Seoul, South Korea
Number of Participants with Adverse Events as a Measure of Safety and Tolerability
Time frame: up to 4 weeks
Time to reach re-epithelialization of wound
Evaluation of the improvement of wound measured by time to reach re-epithelialization of wound
Time frame: 1, 2, 4 weeks
Vancouver Burn Scar Scale
Time frame: 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.